1. An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. (20th November 2020) Authors: Mosca, Alessandra; De Giorgi, Ugo; Procopio, Giuseppe; Basso, Umberto; Cartenì, Giacomo; Bersanelli, Melissa; Naglieri, Emanuele; Galli, Luca; Caffo, Orazio; Fornarini, Giuseppe; Boccardo, Francesco; Porta, Camillo Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 3(2021) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib. (February 2022) Authors: Rebuzzi, Sara Elena; Cerbone, Luigi; Signori, Alessio; Santoni, Matteo; Murianni, Veronica; De Giorgi, Ugo; Procopio, Giuseppe; Porta, Camillo; Milella, Michele; Basso, Umberto; Massari, Francesco; Maruzzo, Marco; Iacovelli, Roberto; Battelli, Nicola; Carmisciano, Luca; Banna, Giuseppe Luigi; But... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab in the treatment of metastatic colorectal cancer. (April 2007) Authors: Caprioni, Francesco; Fornarini, Giuseppe Journal: Future oncology Issue: Volume 3:Number 2(2007) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy. Issue 1 (17th June 2013) Authors: Ottini, Laura; D'Amico, Cristina; Noviello, Cristiana; Lauro, Salvatore; Fornarini, Giuseppe; Colantuoni, Anna; Cortesi, Enrico; Carlini, Sandro; Guadagni, Fiorella; Masala, Giovanna; Bianco, Angelo Raffaele; Contegiacomo, Alma; Palli, Domenico; Mariani-Costantini, Renato Journal: Disease markers Issue: Volume 15:Issue 1/3(1999) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients. Issue 6 (31st March 2019) Authors: Iacovelli, Roberto; Ciccarese, Chiara; Fornarini, Giuseppe; Massari, Francesco; Bimbatti, Davide; Mosillo, Claudia; Rebuzzi, Sara Elena; Di Nunno, Vincenzo; Grassi, Massimiliano; Fantinel, Emanuela; Ardizzoni, Andrea; Tortora, Giampaolo Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 6(2019) Page Start: 1283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program. (7th May 2020) Authors: Tini, Giacomo; Sarocchi, Matteo; Sirello, Davide; Murialdo, Roberto; Fornarini, Giuseppe; Buzzatti, Giulia; Boccardo, Francesco; Arboscello, Eleonora; Porto, Italo; Ameri, Pietro; Spallarossa, Paolo Journal: European journal of preventive cardiology Issue: Volume 28:Number 9(2021) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. Issue 3 (24th February 2012) Authors: Ghiorzo, Paola; Fornarini, Giuseppe; Sciallero, Stefania; Battistuzzi, Linda; Belli, Fiorenza; Bernard, Loris; Bonelli, Luigina; Borgonovo, Giacomo; Bruno, William; De Cian, Franco; DeCensi, Andrea; Filauro, Marco; Faravelli, Francesca; Gozza, Alberto; Gargiulo, Sara; Mariette, Frederique; Nasti,... Journal: Journal of medical genetics Issue: Volume 49:Issue 3(2012) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Direct healthcare costs of non-metastatic castration-resistant prostate cancer in Italy. (6th January 2023) Authors: Borsoi, Ludovica; Ciani, Oriana; Fornarini, Giuseppe; Oderda, Marco; Sciarra, Alessandro; Vetrini, Damir; Luccarini, Irene Journal: International journal of technology assessment in health care Issue: Volume 39:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study. (20th March 2022) Authors: Roviello, Giandomenico; Gambale, Elisabetta; Giorgione, Roberta; Santini, Daniele; Stellato, Marco; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Basso, Umberto; Bimbatti, Davide; Doni, Laura; Nesi, Gabriella; Bersanelli, Melissa; Buti, Sebastiano; De Giorgi, Ugo; Galli, Luca; Sbrana, Andrea; Conca, ... Journal: Cancer medicine Issue: Volume 11:Number 16(2022) Page Start: 3084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status. (February 2023) Authors: Carril-Ajuria, Lucía; Colomba, Emeline; Romero-Ferreiro, Carmen; Cerbone, Luigi; Ratta, Raffaele; Barthelemy, Philippe; Vindry, Clarisse; Fléchon, Aude; Cherifi, François; Boughalem, Elouen; Linassier, Claude; Fornarini, Giuseppe; Rebuzzi, Sara E.; Gross-Goupil, Marine; Saldana, Carolina; Martin-... Journal: European journal of cancer Issue: Volume 180(2023) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗